Lake Street Private Wealth LLC Sells 79 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Lake Street Private Wealth LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 436 shares of the medical equipment provider’s stock after selling 79 shares during the period. Lake Street Private Wealth LLC’s holdings in Intuitive Surgical were worth $228,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in ISRG. TrueWealth Advisors LLC lifted its holdings in shares of Intuitive Surgical by 27.1% during the fourth quarter. TrueWealth Advisors LLC now owns 1,037 shares of the medical equipment provider’s stock worth $541,000 after buying an additional 221 shares during the last quarter. Arthur M. Cohen & Associates LLC raised its stake in Intuitive Surgical by 5.3% during the 4th quarter. Arthur M. Cohen & Associates LLC now owns 10,340 shares of the medical equipment provider’s stock valued at $5,397,000 after purchasing an additional 522 shares during the last quarter. Brooklyn Investment Group boosted its holdings in Intuitive Surgical by 3.4% in the 4th quarter. Brooklyn Investment Group now owns 2,913 shares of the medical equipment provider’s stock valued at $1,520,000 after purchasing an additional 97 shares during the period. Cranbrook Wealth Management LLC grew its position in Intuitive Surgical by 98.4% in the 4th quarter. Cranbrook Wealth Management LLC now owns 244 shares of the medical equipment provider’s stock worth $128,000 after purchasing an additional 121 shares during the last quarter. Finally, Sax Wealth Advisors LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth about $328,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the transaction, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. The trade was a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.80% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of recent research reports. Truist Financial lifted their target price on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Wells Fargo & Company upped their target price on Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a research note on Wednesday, December 11th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Finally, Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Stock Up 1.5 %

Shares of NASDAQ ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68. The firm’s 50-day simple moving average is $540.66 and its 200 day simple moving average is $498.77. The company has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.